Abstract. In the present study we report on four cases other patients treated with quinolones either for a pulmonary of acute interstitial nephritis (AIN ) and two cases of infection (ofloxacin) or for the nephrotic syndrome (pefloxhepatitis induced by quinolone. We show by immunoacin) [4 ], developed cytolytic and cholestatic hepatitis, which blotting analysis that all sera from these patients also resolved after cessation of therapy. One patient also contained autoantibodies that recognize a 65-kDa pro-received clavulanic acid and amoxycillin. The imputability tein expressed in normal human kidney and liver of quinolone was quite strong. As controls, we used 15 microsomes. Only 6% of sera from healthy individuals quinolone-treatedpatients without AIN or hepatitis, 20 who did not ingest quinolone recognized the same patients with AIN or hepatitis induced by other drugs, 13 protein.
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patients under haemodialysis with glomerulonephritis, and finally 16 normal volunteers who never ingested quinolone These findings suggest that the presence of autoanti- ( Table 1 ) .
bodies could be used as a sensitive marker and that a modification of microsomal proteins by quinolone itself or by a metabolite could generated an autoimmune Human kidney and liver microsomes response.
Introduction
Fifty micrograms of human liver and 100 mg of kidney microsomal proteins were subjected to SDS-and then transferred electrophoretically to nitrocellulose sheets as previAcute interstitial nephritis (AIN ) is an uncommon but ously described [7] . Results and discussion dihydralazine [13] . To our knowledge, autoantibodies against a renal autoantigen have not been previously Blood was withdrawn from all subjects, and autoantidetected in drug-induced AIN. In addition to potential bodies against human liver and kidney microsomal interest of our findings for diagnosis, they suggest a proteins were sought by immunoblotting analysis, as common pathogenic mechanism for drug-induced AIN described by Bourdi et al. [8] . As shown in Figure 1 , and hepatitis. This observation should be extended to all sera from patients with quinolone-associated AIN a larger number of patients. It will also be of major or hepatitis recognized a 65-kDa protein in kidney and importance in identifying the autoantigen and its liver microsomes. These autoantibodies were very potential role in quinolone metabolism. uncommon in patients with other kidney diseases (8%, Table 1 ). The percentage of autoantibody-positive sera Acknowledgements. This work was supported by grants Bio 2 CT was slightly higher in the two other control groups. It 920316 and a fellowship from the Institut National de la Santé et could not be ruled out that the latter subjects had de la Recherche Médicale. never been treated with quinolone. By contrast, among healthy volunteers who were checked specifically for the absence of quinolone intake, only 6% had References autoantibodies. Accepted in revised form: 11.4.97
